PAQ Therapeutics Raises $39M in Series B, Starts Phase 1 Trial
07 May 2025 //
PR NEWSWIRE
PAQ Therapeutics Collaborate with Insilico Medicine to Develop Novel Therapies
09 Sep 2021 //
BIOSPACE
07 May 2025 //
PR NEWSWIRE
09 Sep 2021 //
BIOSPACE